No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - Convatec reiterated its full-year guidance on Tuesday after delivering first-half results in line with expectations, with the medical products group forecasting stronger revenue and margins in the second half.
The FTSE 100 company narrowed its forecast for 2026 organic revenue growth, excluding InnovaMatrix, to between 5.5% and 6.5%, from a previous range of 5% to 7%.
It expects organic growth of between 6% and 8% in the second half, led by an acceleration in its Infusion Care business.
Convatec also maintained its forecast for an adjusted operating margin of at least 23%, double-digit adjusted earnings-per-share growth and equity cash conversion of around 100%.
The company said its second-half operating margin would be "materially higher" than the 21.2% recorded in the first six months of 2026, reflecting its normal second-half revenue weighting, faster Infusion Care growth, reduced InnovaMatrix headwinds and further productivity savings.
Revenue for the half ended 30 June rose 4.4% to $1.23bn, while organic growth excluding InnovaMatrix was 5%.
Adjusted operating profit increased 3.9% to $262m, although reported operating profit fell 36.1% to $115m after a $69m impairment related to InnovaMatrix. Adjusted diluted earnings per share rose 6.3% to 8.5cents.
Chief executive Jonny Mason said: "We are on track for another year of margin expansion and double-digit EPS growth. We expect to accelerate growth in H2, supported by new product launches, improving execution and our great team of Convatec colleagues."
Convatec also announced a $200m share buyback and raised its interim dividend by 15.4% to 2.166cents per share.
As of 1407 BST, shares in Convatec were up 1.2% at 228.2p.
The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.